NCT06233331

Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV

RecruitingPHASE1INTERVENTIONAL

Trial Details

Start: 2026-12Est. Completion: 2027-12

Enrollment target: 9 participants

Locations

Grady Memorial Hospital, Atlanta, Georgia, United States

Contact

Lisa Flowers, MD, MPHLflowe2@emory.edu 678-596-3554

Nadine Campbell, MDnadine.campbell@emory.edu 404-251-8794

Other microbiome trials you might be interested in

Testing Immunotherapy Versus Observation in Patients With HPV Throat CancerPhase 3Recruiting

Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

This phase III trials studies whether maintenance immunotherapy (nivolumab) following definitive treatment with radiatio…

Fairhope, United StatesEst. completion Jan 31, 2030

View Trial →

Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine ModelsPhase 2Recruiting

Idiopathic CD4-PositiveT-Lymphocytopenia

Idiopathic CD4 lymphocytopenia (ICL) is a rare syndrome defined by consistently low CD4 T cell counts (\<300/mm\^3) with…

Bethesda, United StatesEst. completion Oct 31, 2030

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.